A Family-Based Association Study of CYP11A1 and CYP11B1 Gene Polymorphisms With Autism in Chinese Trios

Abstract

Autism spectrum disorder is a group of neurodevelopmental disorders with the higher prevalence in males. Our previous studies have indicated lower progesterone levels in the children with autism spectrum disorder, suggesting involvement of the cytochrome P-450scc gene (CYP11A1) and cytochrome P-45011beta gene (CYP11B1) as candidate genes in autism spectrum disorder. The aim of this study was to investigate the family-based genetic association between single-nucleotide polymorphisms, rs2279357 in the CYP11A1 gene and rs4534 and rs4541 in the CYP11B1 gene and autism spectrum disorder in Chinese children, which were selected according to the location in the coding region and 5’ and 3’ regions and minor allele frequencies of greater than 0.05 in the Chinese populations. The transmission disequilibrium test and case-control association analyses were performed in 100 Chinese Han autism spectrum disorder family trios. The genotype and allele frequency of the 3 single-nucleotide polymorphisms had no statistical difference between the children with autism spectrum disorder and their parents (P > .05). Transmission disequilibrium test analysis showed transmission disequilibrium of CYP11A1 gene rs2279357 single-nucleotide polymorphisms (χ² = 5.038, P < .001). Our findings provide further support for the hypothesis that a susceptibility gene for autism spectrum disorder exists within or near the CYP11A1 gene in the Han Chinese population.

Keywords

autism spectrum disorders single nucleotide polymorphisms cytochrome P-450scc gene (CYP11A1)cytochrome P-45011beta gene (CYP11B1)

Get full access to this article

View all access options for this article.

References

Developmental Disabilities Monitoring Network Surveillance Year 2010 Principal Investigators, Centers for Disease Control and Prevention (CDC). Prevalence of autism spectrum disorder among children aged 8 years—autism and developmental disabilities monitoring network, 11 sites, United States, 2010. MMWR Surveill Summ. 2014;63(2):1–21.

Fombonne

. The epidemiology of autism: a review. Psychol Med. 1999;29(4):769–786.

Gillberg

Cederlund

Lamberg

. Brief report: “the autism epidemic.” The registered prevalence of autism in a Swedish urban area. J Autism Dev Disord. 2006;36(3):429–435.

You

Deng

Cen

. Comparative study on changes of serum sex hormone levels in autism children. J Behav Med Brain Sci. 2012;21(11):991–993 [in Chinese].

Katsumata

. Genetic defects in pregnenolone synthesis. Pediatr Endocrinol Rev. 2012;10(suppl 1):98–109.

Bureik

Lisurek

Bernhardt

. The human steroid hydroxylases CYP1B1 and CYP11B2. Biol Chem. 2002;383:1537–1551.

Rutter

Le Couteur

Lord

. Chinese Version of Autism Diagnostic Interview–Revised. Los Angeles, CA: Western Psychological Service; 2007.

Gharani

Waterworth

Batty

. Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism. Hum Mol Genet. 1997;6(3):397–402.

San Millán

Sancho

Calvo

. Role of the pentanucleotide (tttta)(n) polymorphism in the promoter of the CYP11a gene in the pathogenesis of hirsutism. Fertil Steril. 2001;75(4):797–802.

10.

Geier

. A prospective assessment of androgen levels in patients with autistic spectrum disorders: biochemical underpinnings and suggested therapies. Neuro Endocrinol Lett. 2007;28(5):565–573.

11.

Geier

. A clinical and laboratory evaluation of methionine cycle-transsulfuration and androgen pathway markers in children with autistic disorders. Horm Res. 2006;66(4):182–188.

12.

Geier

Kern

King

Sykes

Geier

. An evaluation of the role and treatment of elevated male hormones in autism spectrum disorders. Acta Neurobiol Exp (Wars). 2012;72(1):1–17.

13.

Ingudomnukul

Baron-Cohen

Wheelwright

. Elevated rates of testosterone-related disorders in women with autism spectrum conditions. Horm Behav. 2007;51(5):597–604.

14.

Mefford

Rosenfeld

Shur

. Further clinical and molecular delineation of the 15q24 microdeletion syndrome. J Med Genet. 2012;49(2):110–118.

15.

McInnes

Nakamine

Pilorge

. A large-scale survey of the novel 15q24 microdeletion syndrome in autism spectrum disorders identifies an atypical deletion that narrows the critical region. Mol Autism. 2010;1(1):5.

16.

Chakrabarti

Dudbridge

Kent

. Genes related to sex steroids, neural growth, and social-emotional behavior are associated with autistic traits, empathy, and Asperger syndrome. Autism Res. 2009;2(3):157–177.

17.

Geier

Kern

Geier

. The biological basis of autism spectrum disorders: Understanding causation and treatment by clinical geneticists. Acta Neurobiol Exp (Wars). 2010;70(2):209–226.

18.

Geier

. Autism spectrum disorder-associated biomarkers for case evaluation and management by clinical geneticists. Expert Rev Mol Diagn. 2008;8(6):671–674.

19.

Geier

. A prospective assessment of androgen levels in patients with autistic spectrum disorders: biochemical underpinnings and suggested therapies. Neuro Endocrinol Lett. 2007;28(5):565–573.

20.

Geier

. A clinical trial of combined anti-androgen and anti-heavy metal therapy in autistic disorders. Neuro Endocrinol Lett. 2006;27(6):833–838.

21.

Qiao

Liu

. Identification and functional characterization of a large deletion of the CYP11B1 gene causing an 11beta-Hydroxylase deficiency in a Chinese pedigree. Horm Res Paediatr. 2012;78(4):212–217.

22.

Abbaszadegan

Hassani

Vakili

. Two novel mutations in CYP11B1 and modeling the consequent alterations of the translated protein in classic congenital adrenal hyperplasia patients. Endocrine. 2013;44(1):212–219.

23.

Mellon

Compagnone

Sander

. Rodent models for studying steroids and hypertension: from fetal development to cells in culture. Steroids. 1995;60(1):59–64.

24.

Kaminski

Rogawski

. 11beta-Hydroxylase inhibitors protect against seizures in mice by increasing endogenous neurosteroid synthesis. Neuropharmacology. 2011;61(1-2):133–137.